Medtronic's Melody Transcatheter Pulmonary Valve Gets FDA Panel Date
This article was originally published in The Gray Sheet
FDA's Circulatory System Devices Panel will review a humanitarian device exemption application for Medtronic's Melody transcatheter pulmonary valve and Ensemble delivery system July 22, according to a July 2 Federal Register notice
You may also be interested in...
Medtronic will enter the high-growth, minimally invasive aortic heart valve market through two acquisitions worth more than $1 billion
Feasibility trial results show Medtronic's Melody transcatheter pulmonary heart valve reduces right ventricular volume by 18% in patients with dysfunctional right ventricular outflow tract conduits
Amazon’s motion to dismiss is pending in Washington State’s Western District in litigation concerning Prime subscriptions and alleged “dark patterns” used to trick consumers into enrolling and hinder cancellations, according to the US Federal Trade Commission. The case could be instructive for any and all digital marketers at a time of legal uncertainty surrounding the topic.